Bladder cancer: Pre-existing immunity to BCG can boost clinical response to intravesical therapy

Nature Reviews Urology

Volumn 9, Issue 7, 2012, Pages 354-

  Payton, Sarah ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE;

BCG VACCINATION; BLADDER CANCER; CANCER IMMUNOTHERAPY; CANCER SURVIVAL; DRUG INSTILLATION; HUMAN; LYMPHOCYTIC INFILTRATION; NONHUMAN; NOTE; PRIORITY JOURNAL; RECURRENCE FREE SURVIVAL; T LYMPHOCYTE; TREATMENT RESPONSE;

EID: 84863718408     PISSN: 17594812     EISSN: 17594820     Source Type: Journal    
DOI: 10.1038/nrurol.2012.132     Document Type: Note

References (1)

1. Biot, C. et al. Preexisting BCG-specific T cells improve intravesical immunotherapy for bladder cancer. Sci. Transl. Med. 4, 137ra72 (2012)